| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |